Medicamentos testados em países de baixa e média renda geralmente não estão disponíveis nesses mesmos países, mesmo depois de alguns anos.

Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs – JAMA Network Open

Comentário no Twitter

Sharing benefits and burdens of clinical research? Or not…

Of 70 countries enrolling pts. for new-drug trials, 7% got market access to the drugs they helped test <1 year after FDA approval, 31% did so at 5 years. Lowest access in Africa & Middle East🤨https://t.co/p2uCP43hOG pic.twitter.com/cqsucO1kxP

— Søren M Bentzen (@SorenBentzen) May 6, 2021